Community Oncology Alliance Submits Medicare Hospital Rule Comments Supporting Hospital Pricing Transparency, 340B Rebalancing, and Opposition to Mandatory CMMI Models
September 17, 2021
September 17, 2021
WASHINGTON, Sept. 17 (TNSRep) -- The Community Oncology Alliance issued the following news release:
The Community Oncology Alliance (COA) submitted formal comments to the Centers for Medicare & Medicaid Services (CMS) for the proposed 2022 Medicare Hospital Outpatient Prospective Payment System (OPPS). In the letter, COA expressed support for provisions that would strengthen existing hospital price transparency regulations and continued reforms to the 340B Drug Pricing Program. . . .
The Community Oncology Alliance (COA) submitted formal comments to the Centers for Medicare & Medicaid Services (CMS) for the proposed 2022 Medicare Hospital Outpatient Prospective Payment System (OPPS). In the letter, COA expressed support for provisions that would strengthen existing hospital price transparency regulations and continued reforms to the 340B Drug Pricing Program. . . .